ArticleDigestive diseases and sciences2025

SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks.

Alejandro J Loyola-Vélez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.